Public Holds Favorable Views of Big Pharma, But Still Wants Drug Pricing Reforms

The pharmaceutical industry is gaining popularity with the American public amid the pandemic, according to a recent Data for Progress poll of 1,225 likely voters in late March. Pfizer Inc., Moderna, Inc. and Johnson & Johnson — three pharmaceutical companies that delivered COVID-19 vaccines in less than a year — saw particularly high popularity ratings. Despite the favorable views, the majority of Americans across party lines are supportive of drug pricing reforms, with 73% saying they disapprove of how pharma companies are handling the rising cost of prescription drugs.

 

SOURCE: Data for Progress. Visit https://bit.ly/2PYZk1I.